Yaribeygi, Habib, et al. “Hepatic Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Liver Disorders”. EXCLI Journal, vol. 22, Apr. 2023, pp. 403-14, doi:10.17179/excli2023-6022.